Phytalgic, a Food Supplement, Vs Placebo in Patients with Osteoarthritis of the Knee or Hip: a Randomised Double-blind Placebo-controlled Clinical Trial

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2009 Dec 18

PMID 20015358

Citations 19

Authors

Alain Jacquet

Pierre-Olivier Girodet

Antoine Pariente

Karelle Forest

Laurent Mallet

Nicholas Moore

Affiliations

Soon will be listed here.

Abstract

Introduction: The medicinal treatment of osteoarthritis (OA) is mostly symptomatic to relieve pain and incapacity with analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), drugs with well-known risks. Complementary medicines might reduce the symptoms of OA and decrease the need for NSAIDs. This study tested the effects of a food supplement, Phytalgic, on pain and function in patients with osteoarthritis and their use of analgesic and NSAIDs.

Methods: A randomized double-blind parallel-groups clinical trial compared Phytalgic (fish-oil, vitamin E, Urtica dioica) to a placebo for three months, in 81 patients with OA of the knee or hip using NSAIDs and/or analgesics regularly. The main outcome measures were use of NSAIDs (in Defined Daily Doses per day - DDD/day) or analgesics (in 500 mg paracetamol-equivalent tablets per week (PET/week) measured each month, and Western Ontario-McMaster University Osteo-Arthritis Index (WOMAC) function scales.

Results: After three months of treatment, the mean use of analgesics in the active arm (6.5 PET/week) vs. the placebo arm (16.5) was significantly different (P < 0.001) with a group mean difference of -10.0 (95% CI: -4.9 to -15.1). That of NSAIDs in the active arm (0.4 DDD/day) vs the placebo arm (1.0 DDD/day) was significantly different (P = 0.02) with a group mean difference of - 0.7 DDD/day (95% CI: -0.2 to -1.2). Mean WOMAC scores for pain, stiffness and function in the active arm (respectively 86.5, 41.4 and 301.6) vs the placebo arm (resp. 235.3, 96.3 and 746.5) were significantly different (P < 0.001) with group mean differences respectively of -148.8 (95% CI: -97.7 to -199.9), -54.9 (95% CI: -27.9 to -81.9) and -444.8 (95% CI: -269.1 to -620.4).

Conclusions: The food supplement tested appeared to decrease the need for analgesics and NSAIDs and improve the symptoms of osteoarthritis.

Trial Registration: Clinicaltrials.gov NCT00666523.

Citing Articles

Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial.

Vaidya N, Agarwal R, Dipankar D, Patkar H, Ganu G, Nagore D Pharm Res. 2025; 42(2):249-269.

PMID: 39875757 PMC: 11880083. DOI: 10.1007/s11095-025-03818-2.

Omega-3 Supplementation and Its Effects on Osteoarthritis.

Shawl M, Geetha T, Burnett D, Babu J Nutrients. 2024; 16(11).

PMID: 38892583 PMC: 11174396. DOI: 10.3390/nu16111650.

The Role of Polyunsaturated Fatty Acids in Osteoarthritis: Insights from a Mendelian Randomization Study.

Li X, Lu Z, Qi Y, Chen B, Li B Nutrients. 2023; 15(22).

PMID: 38004181 PMC: 10674676. DOI: 10.3390/nu15224787.

Targeting the Inflammatory Hallmarks of Obesity-Associated Osteoarthritis: Towards Nutraceutical-Oriented Preventive and Complementary Therapeutic Strategies Based on n-3 Polyunsaturated Fatty Acids.

Gambari L, Cellamare A, Grassi F, Grigolo B, Panciera A, Ruffilli A Int J Mol Sci. 2023; 24(11).

PMID: 37298291 PMC: 10253881. DOI: 10.3390/ijms24119340.

Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis.

Deng W, Yi Z, Yin E, Lu R, You H, Yuan X J Orthop Surg Res. 2023; 18(1):381.

PMID: 37226250 PMC: 10210278. DOI: 10.1186/s13018-023-03855-w.

References

Darlington L, Stone T . Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr. 2001; 85(3):251-69. DOI: 10.1079/bjn2000239. View

Bruyere O, Reginster J . Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging. 2007; 24(7):573-80. DOI: 10.2165/00002512-200724070-00005. View

Bjordal J, Klovning A, Ljunggren A, Slordal L . Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain. 2006; 11(2):125-38. DOI: 10.1016/j.ejpain.2006.02.013. View

Moore N . Place of OTC analgesics and NSAIDs in osteoarthritis. Inflammopharmacology. 2004; 11(4):355-62. DOI: 10.1163/156856003322699537. View

Ernst E . Complementary and alternative medicine in rheumatology. Baillieres Best Pract Res Clin Rheumatol. 2000; 14(4):731-49. DOI: 10.1053/berh.2000.0110. View

Curtis C, Rees S, Cramp J, Flannery C, Hughes C, Little C . Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc. 2002; 61(3):381-9. DOI: 10.1079/PNS2002174. View

Randall C, Randall H, Dobbs F, Hutton C, Sanders H . Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med. 2000; 93(6):305-9. PMC: 1298033. DOI: 10.1177/014107680009300607. View

Singh G, Wu O, Langhorne P, Madhok R . Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther. 2006; 8(5):R153. PMC: 1779447. DOI: 10.1186/ar2047. View

. [General practice study with nettle extract. Arthrosis patient need fewer non-steroidal anti-inflammatory drugs]. MMW Fortschr Med. 2002; 144(26):52. View

10.

Deal C, Moskowitz R . Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am. 1999; 25(2):379-95. DOI: 10.1016/s0889-857x(05)70074-0. View

11.

Hochberg M, Dougados M . Pharmacological therapy of osteoarthritis. Best Pract Res Clin Rheumatol. 2001; 15(4):583-93. DOI: 10.1053/berh.2001.0175. View

12.

Clayton J . Nutraceuticals in the management of osteoarthritis. Orthopedics. 2007; 30(8):624-9. DOI: 10.3928/01477447-20070801-13. View

13.

Wertheimer A . The defined daily dose system (DDD) for drug utilization review. Hosp Pharm. 1986; 21(3):233-4, 239-41, 258. View

14.

Mazieres B, Hucher M, Zaim M, Garnero P . Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2007; 66(5):639-45. PMC: 1954603. DOI: 10.1136/ard.2006.059899. View

15.

Ameye L, Chee W . Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006; 8(4):R127. PMC: 1779427. DOI: 10.1186/ar2016. View

16.

Roggeri D, Saramin C, Terrazzani G, Zusso M, Giusti P, Chinellato A . Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy. Pharmacol Res. 2007; 56(4):329-34. DOI: 10.1016/j.phrs.2007.08.001. View

17.

Chrubasik J, Roufogalis B, Wagner H, Chrubasik S . A comprehensive review on nettle effect and efficacy profiles, Part I: herba urticae. Phytomedicine. 2007; 14(6):423-35. DOI: 10.1016/j.phymed.2007.03.004. View

18.

Moore N, Diris H, Martin K, Viale R, Fourrier A, Moride Y . NSAID use profiles derived from reimbursement data in France. Therapie. 2005; 59(5):541-6. DOI: 10.2515/therapie:2004092. View

19.

Whitehouse M, Rainsford K, Taylor R, Vernon-Roberts B . Zinc monoglycerolate: a slow-release source of zinc with anti-arthritic activity in rats. Agents Actions. 1990; 31(1-2):47-58. DOI: 10.1007/BF02003221. View

20.

Wolfe M, Lichtenstein D, Singh G . Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999; 340(24):1888-99. DOI: 10.1056/NEJM199906173402407. View